ArticleDiabetes, obesity & metabolism2018
This is in reply to the Letter by Kahathuduwa et al. titled "Unaccounted for regression to the mean renders conclusion of article titled 'Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor Tofogliflozin' unsubstantiated".
Motoshi Ouchi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.